The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)—The IKF-IMMULAB trial.
 
Arndt Vogel
Honoraria - Amgen; AstraZeneca/MedImmune; BeiGene; Boehringer Pharma GmbH; Boston Scientific; Bristol-Myers Squibb; Daichi-Sankyo; Eisai; GlaxoSmithKline; Incyte; Ipsen; Janssen; Lilly; MSD; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Sirtex Medical; Taiho Oncology; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Boehringer Pharma GmbH; BTG; Daichi-Sankyo; EISAI; Incyte; IPSEN; Lilly; Novartis; Pierre Fabre; Roche; Sirtex Medical; Taiho Oncology; Taiho Oncology; Terumo
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Lilly; MSD; Roche
 
Oliver Waidmann
Honoraria - Advanz Pharma; Amgen; AstraZeneca; Bayer; BMS; Eisai; Falk Foundation; Incyte; Ipsen; Merck; MSD; Novartis; Pierre Fabre; Roche; Servier; Zentiva; Zentiva
Consulting or Advisory Role - AstraZeneca; Bayer; BMS; Eisai; Falk Foundation; Incyte; Ipsen; Merck Serono; MSD; Novartis; Roche; Servier
Research Funding - Merck Serono
Travel, Accommodations, Expenses - AstraZeneca; BMS; Ipsen; Merck Serono; Pierre Fabre; Roche
 
Thomas Wirth
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Merck; MSD; Novartis; Pierre Fabre; Roche; SERVIER; Viatris
Research Funding - Bristol-Myers Squibb; Hookipa Biotech
 
Mueller Tobias
No Relationships to Disclose
 
Raphael Mohr
No Relationships to Disclose
 
Gabriele Siegler
Honoraria - AstraZeneca; Aurikamed; BDI; Deutsche Röntgengesellschaft; Ipsen; Janssen; MCI Deutschland; Meet the Experts Academy; SERVIER
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; Novartis; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; MCI Deutschland; Merck; Pierre Fabre; SERVIER
 
Thorsten Goetze
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Foundation Medicine; Incyte; Lilly; MSD Oncology; Novartis; Roche; SERVIER
Speakers' Bureau - Lilly; MSD Oncology
Research Funding - AstraZeneca (Inst); Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss; Incyte (Inst); Lilly (Inst)
 
Enrico De Toni
Employment - Boehringer Ingelheim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Research Funding - AstraZeneca; Bayer; Bristol-Myer Squibb; Ipsen; Lilly; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Celsion; IPSEN; Roche
 
Alexander Philipp
Honoraria - Falk Foundation; Pfizer
Consulting or Advisory Role - Roche
Research Funding - AstraZeneca; Roche
Travel, Accommodations, Expenses - Roche
 
Maria Gonzalez-Carmona
No Relationships to Disclose
 
Guido Hausner
No Relationships to Disclose
 
Michael Geissler
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Angelika Kestler
No Relationships to Disclose
 
Fabian Finkelmeier
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD; Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Ipsen
 
Jorge Klagges
No Relationships to Disclose
 
Regina Eickhoff
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Frankfurter Institut für Klinische Krebsforschung IKF GmbH
Consulting or Advisory Role - Bristol-Myers Squibb; Eli Lilly Germany; Merck Sharp & Dohme
Speakers' Bureau - MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Immutep; Ipsen; Lilly; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma
 
Anna Saborowski
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; MSD; Roche; Servier
Consulting or Advisory Role - Eisai; MSD
Travel, Accommodations, Expenses - MSD; Pierre Fabre; SERVIER